top of page

On conference circuit, biotechs lobby for their identity as new IRA drug pricing reforms take hold

The biotech industry split off into two conference camps in early June: Oncology researchers headed to Chicago for the American Society of Clinical Oncology (ASCO) meeting, while business development folks gathered in Boston for the BIO International Convention. But one theme loomed large over both events: the Inflation Reduction Act (IRA)...


bottom of page